Endocrinology, Vol 133, 1602-1608, Copyright © 1993 by Endocrine Society

ARTICLES

Evidence that the growth hormone receptor mediates differentiation and development of the mammary gland

M Feldman, W Ruan, BC Cunningham, JA Wells and DL Kleinberg
Department of Medicine, Department of Veterans Affairs Medical Center, New York, New York 10010.

We have shown that nonlactogenic rat (r) GH is far more potent than rPRL in inducing rat mammary development. To determine the relative roles of GH and PRL in mammary development and their mechanisms of action, we have compared the abilities of a group of native and mutant GHs, PRLs, and placental lactogens (PLs) to induce mammary development, bind to GH receptors, and activate lactogenic receptors. Mammary development was assessed histologically by counting terminal end buds and alveolar structures in glands from sexually immature, hypophysectomized, castrated, estradiol-treated rats. Hormones were implanted, in Elvax pellets, into the lumbar mammary gland. Significant increases in terminal end buds (P < 0.03) over internal control values were obtained with rGH, recombinant human GH (rhGH), rbGH, and one of two mutant rhGHs. These four hormones were also found to bind to GH receptors with high affinity. In contrast, little development occurred with hPRL, rPRL, rhPL, ovine PRL, mutant forms of rhPRL and rhPL, and a mutant of rhGH altered to reduce binding to GH and PRL receptors. All of these substances are more than 50-fold reduced in binding to the GH receptor, yet can bind and activate lactogenic receptors. Thus, only those natural or mutant pituitary or placental hormones with high binding affinity to GH receptors induce mammary development, suggesting that GH receptors play a central role in this process.

This article has been cited by other articles:

				J. N. Lucas, D. G. Rudmann, K. M. Credille, A. R. Irizarry, A. Peter, and P. W. Snyder Invited Review: The Rat Mammary Gland: Morphologic Changes as an Indicator of Systemic Hormonal Perturbations Induced by Xenobiotics Toxicol Pathol, February 1, 2007; 35(2): 199 - 207. [Abstract] [PDF]

				X. Zhang, R. G. Mehta, D. D. Lantvit, K. T. Coschigano, J. J. Kopchick, J. E. Green, S. Hedayat, K. T. Christov, V. H. Ray, T. G. Unterman, et al. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling Carcinogenesis, January 1, 2007; 28(1): 143 - 150. [Abstract] [Full Text] [PDF]

				S. Mukhina, D. Liu, K. Guo, M. Raccurt, S. Borges-Bendris, H. C. Mertani, and P. E. Lobie Autocrine Growth Hormone Prevents Lactogenic Differentiation of Mouse Mammary Epithelial Cells Endocrinology, April 1, 2006; 147(4): 1819 - 1829. [Abstract] [Full Text] [PDF]

				W. Ruan, F. Fahlbusch, D. R. Clemmons, M. E. Monaco, P. D. Walden, A. P. Silva, H. A. Schmid, and D. L. Kleinberg SOM230 Inhibits Insulin-Like Growth Factor-I Action in Mammary Gland Development by Pituitary Independent Mechanism: Mediated through Somatostatin Subtype Receptor 3? Mol. Endocrinol., February 1, 2006; 20(2): 426 - 436. [Abstract] [Full Text] [PDF]

				W. Ruan, M. E. Monaco, and D. L. Kleinberg Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action Endocrinology, March 1, 2005; 146(3): 1170 - 1178. [Abstract] [Full Text] [PDF]

				G. J. Allan, E. Tonner, M. C. Barber, M. T. Travers, J. H. Shand, R. G. Vernon, P. A. Kelly, N. Binart, and D. J. Flint Growth Hormone, Acting in Part through the Insulin-Like Growth Factor Axis, Rescues Developmental, But Not Metabolic, Activity in the Mammary Gland of Mice Expressing a Single Allele of the Prolactin Receptor Endocrinology, November 1, 2002; 143(11): 4310 - 4319. [Abstract] [Full Text] [PDF]

				S. M. Swanson and T. G. Unterman The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis Carcinogenesis, June 1, 2002; 23(6): 977 - 982. [Abstract] [Full Text] [PDF]

				W. Ruan and D. L. Kleinberg Insulin-Like Growth Factor I Is Essential for Terminal End Bud Formation and Ductal Morphogenesis during Mammary Development Endocrinology, November 1, 1999; 140(11): 5075 - 5081. [Abstract] [Full Text]

				W. Ruan, L. Powell-Braxton, J. J. Kopchick, and D. L. Kleinberg Evidence That Insulin-Like Growth Factor I and Growth Hormone Are Required for Prostate Gland Development Endocrinology, May 1, 1999; 140(5): 1984 - 1989. [Abstract] [Full Text]

				P. D. Walden, W. Ruan, M. Feldman, and D. L. Kleinberg Evidence That the Mammary Fat Pad Mediates the Action of Growth Hormone in Mammary Gland Development Endocrinology, February 1, 1998; 139(2): 659 - 662. [Abstract] [Full Text] [PDF]

				T. J. J. Wood, D. Sliva, P. E. Lobie, T. J. Pircher, F. Gouilleux, H. Wakao, J. Gustafsson, B. Groner, G. Norstedt, and , and Lars-Arne Haldosén Mediation of Growth Hormone-dependent Transcriptional Activation by Mammary Gland Factor/Stat 5 J. Biol. Chem., April 21, 1995; 270(16): 9448 - 9453. [Abstract] [Full Text] [PDF]

				H. C. Mertani, T. Zhu, E. L. K. Goh, K.-O. Lee, G. Morel, and P. E. Lobie Autocrine Human Growth Hormone (hGH) Regulation of Human Mammary Carcinoma Cell Gene Expression. IDENTIFICATION OF CHOP AS A MEDIATOR OF hGH-STIMULATED HUMAN MAMMARY CARCINOMA CELL SURVIVAL J. Biol. Chem., June 8, 2001; 276(24): 21464 - 21475. [Abstract] [Full Text] [PDF]